Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
03/17/2026 - 18:38
PHARMANUTRA
NOTICE OF CALLING OF THE ORDINARY SHAREHOLDERS’ MEETING
03/17/2026 - 18:36
PHARMANUTRA
Avviso di convocazione Assemblea ordinaria degli azionisti
03/17/2026 - 17:43
PHARMANUTRA
PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025
03/17/2026 - 17:41
PHARMANUTRA
PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025
03/03/2026 - 07:48
PHARMANUTRA
PHARMANUTRA - PHN - PARTNERSHIP SIGNED FOR THE DISTRIBUTION OF SIDERAL PRODUCTS IN FRANCE AND SWITZERLAND
03/03/2026 - 07:45
PHARMANUTRA
PHARMANUTRA - PHN - SIGLATA PARTNERSHIP PER LA DISTRIBUZIONE DEI PRODOTTI SIDERAL IN FRANCIA E SVIZZERA
02/23/2026 - 18:01
PHARMANUTRA
PHARMANUTRA - PHN - GUIDELINES OF THE BOD TO SHAREHOLDERS ON THE FUTURE SIZE AND COMPOSITION OF THE NEW BOD - APPOINTMENT OF THE INVESTOR RELATIONS DIRECTOR
02/23/2026 - 17:58
PHARMANUTRA
PHARMANUTRA - PHN - ORIENTAMENTI DEL CDA AGLI AZIONISTI SULLA FUTURA DIMENSIONE E COMPOSIZIONE DEL NUOVO CDA - NOMINA DELL’INVESTOR RELATOR
01/12/2026 - 17:52
PHARMANUTRA
PHARMANUTRA PHN - PRELIMINARY REVENUES 2025
01/12/2026 - 17:49
PHARMANUTRA
PHARMANUTRA PHN - RICAVI PRELIMINARI 2025
12/16/2025 - 12:50
PHARMANUTRA
PHARMANUTRA - Corporate events calendar 2026
12/16/2025 - 12:45
PHARMANUTRA
PHARMANUTRA Calendario Eventi societari 2026
11/17/2025 - 08:00
PHARMANUTRA
PHARMANUTRA S.P.A. TRA LE IMPRESE A MAGGIOR SVILUPPO SOSTENIBILE NEL RANKING MONDIALE DELLA RIVISTA “TIME”
11/17/2025 - 08:00
PHARMANUTRA
PHARMANUTRA S.P.A. LISTED AMONG THE WORLD’S BEST COMPANIES FOR SUSTAINABLE GROWTH BY “TIME” MAGAZINE
11/13/2025 - 09:58
PHARMANUTRA
Interim Management report as at September 30 2025
11/13/2025 - 09:56
PHARMANUTRA
Resoconto Intermedio di gestione al 30 settembre 2025
11/13/2025 - 09:54
PHARMANUTRA
Avviso deposito Rendiconto Intermedio di gestione al 30 settembre 2025 || Notice of Filing of Interim Management Report as of September 30 2025
11/10/2025 - 17:51
PHARMANUTRA
PHARMANUTRA S.P.A.: BOARD OF DIRECTORS APPROVES THE INTERIM MANANGEMENT REPORT AS OF SEPTEMBER 30, 2025
11/10/2025 - 17:49
PHARMANUTRA
PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025
11/04/2025 - 11:34
PHARMANUTRA
ALLEGATO 3F - OTTOBRE 2025
10/20/2025 - 08:00
PHARMANUTRA
“SIDERAL® FORTE” PREMIATO COME MIGLIOR PRODOTTO NUTRACEUTICO || “SIDERAL® FORTE” AWARDED BEST NUTRACEUTICAL PRODUCT
10/03/2025 - 13:13
PHARMANUTRA
Initiation of share buy-back program
10/03/2025 - 13:12
PHARMANUTRA
Avvio del programma di acquisti di azioni proprie
09/12/2025 - 10:33
PHARMANUTRA
CS_Disponibilità Relazione Semestrale 2025 || Availability Half Year financial report 2025

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are